Overview
Katsuyuki Aozasa practices practicing medicine in Suita, Japan.
Their clinical expertise encompasses Midline Lethal Granuloma and Diffuse Large B-Cell Lymphoma (DLBCL).
They are actively involved in clinical research, co-authoring 14 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Katsuyuki Aozasa
Is Katsuyuki Aozasa a top-rated expert for Midline Lethal Granuloma?
MediFind is an objective health platform that identifies experts based on real-world data. Katsuyuki Aozasa is classified as an Experienced expert for Midline Lethal Granuloma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Katsuyuki Aozasa participate in research or clinical trials?
Yes. Katsuyuki Aozasa has published 14 articles and abstracts on conditions like Midline Lethal Granuloma. You can view a list of Katsuyuki Aozasa's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Diffuse Large B-Cell Lymphoma (DLBCL)
- Midline Lethal GranulomaAozasa isExperienced. Learn about Midline Lethal Granuloma.